ACS
BNGO icon

Archford Capital Strategies’s Bionano Genomics BNGO Stock Holding History

Archford Capital Strategies’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,159
Closed -$20.1K – 291
2024
Q4 		$20.1K Hold
1,159
– – ﹤0.01% 266
2024
Q3 		$24.4K Hold
1,159
– – ﹤0.01% 253
2024
Q2 		$47.2K Hold
1,159
– – 0.01% 257
2024
Q1 		$77.2K Hold
1,159
– – 0.01% 258
2023
Q4 		$131K Sell
1,159
-525
-31% -$54.8K 0.02% 249
2023
Q3 		$306K Buy
1,684
+909
+117% +$238K 0.06% 234
2023
Q2 		$271K Buy
775
+131
+20% +$59.1K 0.05% 248
2023
Q1 		$398K Buy
644
+512
+388% +$455K 0.08% 218
2022
Q4 		$116K Hold
132
– – 0.03% 267
2022
Q3 		$145K Hold
132
– – 0.04% 265
2022
Q2 		$110K Hold
132
– – 0.03% 257
2022
Q1 		$206K Hold
132
– – 0.05% 269
2021
Q4 		$238K Sell
132
-202
-60% -$540K 0.05% 278
2021
Q3 		$1.1M Buy
334
+50
+18% +$175K 0.26% 98
2021
Q2 		$1.25M Hold
284
– – 0.31% 80
2021
Q1 		$1.04M Buy
284
+168
+145% +$947K 0.28% 97
2020
Q4 		$328K Buy
+116
New +$43.3K 0.08% 224

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Archford Capital Strategies's BNGO Position: Q1 2025 in Review

Archford Capital Strategies sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 1,159 shares — an estimated $20.1K sold.

Archford Capital Strategies first reported a position in BNGO in Q4 2020 and held it in 17 quarters. The position peaked at $1.25M in Q2 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Archford Capital Strategies reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • Archford Capital Strategies sold 1,159 Bionano Genomics shares in Q1 2025, an estimated $20.1K.
  • Archford Capital Strategies first reported a position in Bionano Genomics in Q4 2020 and held it in 17 quarters.
  • Archford Capital Strategies's Bionano Genomics position peaked at $1.25M in Q2 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Archford Capital Strategies's 13F filing for Q1 2025, filed 23 Apr 2025.